(1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Cole Derek Cecil
公开号:US06951881B2
公开(公告)日:2005-10-04
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
本发明提供了一种I式化合物,以及其在治疗与或受5-HT6受体相关的疾病中的应用。
US6951881B2
申请人:——
公开号:US6951881B2
公开(公告)日:2005-10-04
Iminyl-radicals by electrochemical decarboxylation of α-imino-oxy acids: construction of indole-fused polycyclics
Iminyl radicals are reactive intermediates that can be used for the construction of various valuable heterocycles. Herein, the electrochemical decarboxylation of α-imino-oxy acids for the generation of iminyl radicals has been accomplished under exogenous-oxidant- and metal-free conditions through the use of nBu4NBr as a mediator. The resulting iminyl radicals undergo intramolecular cyclization smoothly
亚胺基是反应性中间体,可用于构建各种有价值的杂环。在此,通过使用n Bu 4 NBr 作为介体,在无外源氧化剂和无金属条件下完成了用于产生亚胺基自由基的 α-亚氨基-羟基酸的电化学脱羧。所得亚胺基自由基与相邻的(杂)芳烃顺利进行分子内环化,得到一系列吲哚稠合的多环化合物。
(1-Substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
申请人:Wyeth
公开号:US20030232843A1
公开(公告)日:2003-12-18
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of a disorder relating to or affected by the 5-HT6 receptor.
1